Bone Marrow TransplantationTissue DonorsTransplantation, HomologousHistocompatibility TestingGraft vs Host DiseaseHistocompatibilityBone MarrowGraft SurvivalBone Marrow CellsTransplantation ChimeraWhole-Body IrradiationTransplantation, AutologousTransplantation ConditioningSurvival AnalysisAnemia, AplasticLeukemiaHematopoietic Stem Cell TransplantationGraft RejectionKidney TransplantationBone and BonesImmunosuppressive AgentsTransplantation, IsogeneicTransplantation ToleranceLiver TransplantationRadiation ChimeraGraft Enhancement, ImmunologicHematopoietic Stem CellsHeart TransplantationImmunosuppressionLeukocyte TransfusionMice, Inbred C57BLBusulfanRecurrenceTransplantation ImmunologySkin TransplantationBone Marrow PurgingHLA AntigensTreatment OutcomeTime FactorsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte DepletionChimerismActuarial AnalysisPrecursor Cell Lymphoblastic Leukemia-LymphomaCyclophosphamideBone Marrow DiseasesT-LymphocytesAcute DiseaseHematopoiesisCombined Modality TherapyLiving DonorsLeukemia, Myeloid, AcuteChlorophyllidesBone Marrow ExaminationLung TransplantationLymphocyte Culture Test, MixedRemission InductionHepatic Veno-Occlusive DiseaseChimeraBone RemodelingGraft vs Host ReactionStem Cell TransplantationRetrospective StudiesMice, Inbred BALB CBone Marrow NeoplasmsLeukemia, MyeloidCyclosporineLymphoma, Non-HodgkinLymphocyte TransfusionDisease-Free SurvivalSevere Combined ImmunodeficiencyColony-Forming Units AssayMyelodysplastic SyndromesCytomegalovirus InfectionsTransplantationHematologic DiseasesFollow-Up StudiesBlood DonorsTransplantsImmune ToleranceBone DensityMice, Inbred C3HSurvival RateNuclear FamilyAntineoplastic Combined Chemotherapy ProtocolsFlow CytometryOrgan TransplantationGraft vs Tumor EffectCarmustineCell DifferentiationPancytopeniaGraft vs Leukemia EffectLeukocyte CountCytarabineSpleenPostoperative ComplicationsGranulocyte Colony-Stimulating FactorMelphalanBone ResorptionFatal Outcome